Articles Tập 67 Số CĐ14-HNKH Hội Hóa sinh Y học Việt Nam 19/09/2026

PREVALENCE OF METABOLIC SYNDROME AND ITS ASSOCIATION WITH BIOCHEMICAL PARAMETERS IN PATIENTS WITH TYPE 2 DIABETES AT BAC KAN GENERAL HOSPITAL IN 2025.

Hoang Xuan Son, Pham Thi Nguyet, Nguyen Xuan Dat, Vu Thi Bich Hong, Phung Duc Hien, Hoang Huyen Huong, Pham Thi Bich Hang, Ha Dieu Van, Dong Thi Duoc, Pham Thi Bich Hang, Trieu Thi Bien, Nong Van Diep, Nguyen Thi Kieu Oanh
DOI: 10.52163/yhc.v67iCD14.6463
0 Views
0 Downloads
Abstract

Objective: To determine the prevalence of metabolic syndrome and its associated factors in patients with type 2 diabetes mellitus, and to compare selected biochemical parameters between patients with and without metabolic syndrome.

Methods: A cross sectional study was conducted on 202 outpatients with type 2 diabetes mellitus at Bac Kan General Hospital from January 2025 to July 2025. Eligible patients were enrolled according to the inclusion criteria. Biochemical analyses were performed using the Beckman Coulter AU680 analyzer.

Results: The prevalence of metabolic syndrome among patients with type 2 diabetes mellitus was 67.8%. Factors significantly associated with metabolic syndrome included female sex, age ≥ 60 years, and body mass index (BMI) ≥ 25 kg/m²(p < 0.05). Patients with metabolic syndrome had significantly higher mean triglyceride levels and lower HDL-C concentrations compared with those without metabolic syndrome(p < 0.05).

Conclusions: The majority of patients with type 2 diabetes mellitus had concomitant metabolic syndrome, particularly female patients. Metabolic syndrome was associated with dyslipidemia and overweight status, highlighting the importance of comprehensive management of metabolic syndrome components in patients with type 2 diabetes mellitus.

Keywords
Metabolic syndrome; type 2 diabetes mellitus; biochemical parameters; dyslipidemia.
References
[1]
1. Samson SL, Garber AJ. Metabolic syndrome. Endocrinol Metab Clin North Am. 2014 Mar;43(1):1-23. Google Scholar
[2]
2. Li W, Q Xinfan, M Huan, G Qingshan. Incidence and long-term specific mortality trends of metabolic syndrome in the United States. Frontiers in endocrinology. 2023, 13:1029736. Google Scholar
[3]
3. Vũ Thị Lan Phương, Nguyễn Trọng Hưng, Phan Hướng Dương, Nguyễn Thị Lan Hương. Hội chứng chuyển hóa ở người bệnh đái tháo đường type 2 điều trị nội trú tại Bệnh viện Nội tiết Trung ương, năm 2019–2020. Tạp chí Dinh dưỡng & Thực phẩm. 2020;16(2):111-119. Google Scholar
[4]
4. Nguyễn Thị Huỳnh Như, Nguyễn Thị Kim Vân, Nguyễn Tam Anh. Khảo sát tỉ lệ hội chứng chuyển hóa ở người bệnh đái tháo đường type 2 đang điều trị tại Bệnh viện Trường Đại học Trà Vinh. Tạp chí Y học Việt Nam. 2023; (số đặc biệt tháng 3):44-50. Google Scholar
[5]
5. American Diabetes Association. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes 2022. Diabetes Care. 2022;45(Suppl 1):S17–S38. Google Scholar
[6]
6. Alberti KGMM, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A Joint Interim Statement. Circulation. 2009;120(16):1640–1645. Google Scholar
[7]
7. Belete R, et al. Global prevalence of metabolic syndrome among T2DM patients: A meta-analysis. Diabetes Metab Syndr. 2021;15(1):189–197. Google Scholar
[8]
8. Huxley R, Barzi F, Woodward M. Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ. 2006;332(7533):73–78. Google Scholar
[9]
9. Kautzky-Willer A, Harreiter J, Pacini G. Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus. Endocr Rev. 2016;37(3):278–316. Google Scholar
[10]
10. Alberti KGMM, Zimmet P, Shaw J, et al. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. 2006. Google Scholar
[11]
11. Eshtiaghi R, Esteghamati A, Nakhjavani M. Gender differences in the metabolic syndrome and its components in the Iranian adult population: Tehran Lipid and Glucose Study. Int J Endocrinol Metab. 2010;8(2):87–93. Google Scholar